RecruitingNCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Studying Sarcoma of cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Adela, Inc
- Principal Investigator
- Brian Rini, MDVanderbilt-Ingram Cancer Center
- Enrollment
- 7000 enrolled
- Eligibility
- 40 years · All sexes
- Timeline
- 2022 – 2027
Study locations (17)
- City of Hope, Duarte, California, United States
- Miami Cancer Institute, Miami, Florida, United States
- North Georgia Health System, Gainesville, Georgia, United States
- Baptist Floyd, New Albany, Indiana, United States
- Baptist Corbin, Corbin, Kentucky, United States
- Baptist Hardin, Elizabethtown, Kentucky, United States
- Baptist Lexington, Lexington, Kentucky, United States
- Baptist Paducah, Paducah, Kentucky, United States
- Allina Health Cancer Institute, Minneapolis, Minnesota, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Oregon Health Sciences University, Portland, Oregon, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- McLeod Health, Florence, South Carolina, United States
- Baptist (BHMCC), Memphis, Tennessee, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05366881 on ClinicalTrials.govOther trials for Sarcoma of cervix uteri
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07071727Short Course of Radiotherapy Prior to Surgery of Soft Tissue SarcomasThe Netherlands Cancer Institute
- RECRUITINGPHASE2NCT07192068Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.UNICANCER
- RECRUITINGPHASE1NCT06771219SLV-154 Treatment of Metastatic Solid TumorsSolve Therapeutics
- RECRUITINGNCT06904365Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenWashington University School of Medicine
- RECRUITINGPHASE2NCT06580002Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialUniversity of California, Irvine
- RECRUITINGNANCT06103669Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)University of California, Davis
- RECRUITINGPHASE1, PHASE2NCT05187338Triplex Checkpoint Inhibitors Therapy for Advanced Solid TumorsSecond Affiliated Hospital of Guangzhou Medical University
- RECRUITINGNANCT03017573Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)Institut Curie